CFR section

21 CFR 212.50(b)(4): What production and process controls must I have?

PART 212-CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS · Subpart F-Production and Process Controls

Key facts

Citation 21 CFR 212.50(b)(4)
Section What production and process controls must I have?
Part PART 212-CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
Subpart Subpart F-Production and Process Controls
Subchapter 21 CFR C Drugs General
Product types cited Drugs
Regulation text (excerpt) (4) Identification of all major pieces of equipment used in production;

At a glance

  • 1–9 Inspections citing this section
  • None Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA